Skip to main content
. Author manuscript; available in PMC: 2023 Jun 22.
Published in final edited form as: J Am Pharm Assoc (2003). 2022 Dec 31;63(3):769–777. doi: 10.1016/j.japh.2022.12.028

Table 4.

Unadjusted and adjusted multivariable models examining regimen characteristics and health-related factors with A1C

Variable Unadjusted model
Adjusted with overall MRCI
B (95% CI) P value B (95% CI) P value
Age
 < 50 ----- -----
 50–63 −0.60 (−1.07, −0.14) 0.01 −0.12 (−0.65, 0.42) 0.40
 64+ −0.98 (−1.52, −0.43) 0.001 −0.26 (−0.83, 0.31) 0.37
Gender
 Female ----- -----
 Male 0.65 (0.25, 1.04) 0.001 0.58 (0.16, 0.99) 0.01
Household income
 Less than $15,000 ----- -----
 $15,000-$30,000 0.20 (−0.22, 0.61) 0.36 −0.02 (−0.46, 0.41) 0.91
 More than $30,000 1.00 (0.36, 1.64) 0.01 0.53 (−0.17, 1.23) 0.14
Insurance
 Self-pay/none ----- -----
 Medicare + Medicaid −1.06 (−1.71, −0.42) 0.001 −1.15 (−1.90, −0.39) 0.01
 Medicare −1.02 (−1.57, −0.46) 0.001 −0.94 (−1.56, −0.32) 0.01
 Medicaid −0.68 (−1.79, −0.18) 0.01 −0.71 (−1.26, −0.17) 0.01
 Private/HMO −−0.30 (−0.96, 0.35) 0.37 −0.55 (−1.27, 0.17) 0.17
Overall MRCI
 <14 ----- -----
 14–18.4 0.74 (0.21, 1.28) 0.01 0.97 (0.40, 1.54) 0.01
 18.5–26 0.74 (0.19, 1.30) 0.01 1.04 (0.45, 1.64) 0.01
 >26 0.46 (−0.07, 0.99) 0.09 1.13 (0.53, 1.72) 0.001
Outpatient visit utilization (past 6 mo)
 1 ----- -----
 2 −0.35 (−0.86, 0.16) 0.17 −0.35 (−0.86, 0.16) 0.17
 3–4 −0.45 (−1.01, 0.11) 0.11 −0.45 (−1.01, 0.11) 0.11
 5+ −0.92 (−1.53, −0.30) 0.01 −0.92 (−1.53, −0.30) 0.01

Abbreviations used: HMO, health maintenance organization; B, beta coefficient; MRCI, medication regimen complexity index.

Note: Adjusted models included all variables in the table (with MRCI as the exception) and adjusted for intervention arm and number of days between baseline interview and A1C collection date.